Transaction · 0000874015-26-000134

BENNETT C FRANK

BENNETT C FRANK, EVP, CSO, reported a transaction classified as exercise at IONIS PHARMACEUTICALS INC involving 48626.000000 shares for an estimated $2960837.14. Reported holdings after the transaction were 165643.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MEVP, CSO
IONSIONIS PHARMACEUTICALS INC
Filing timeMar 05
Trade dateMar 03, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$75.16
Pre-filing
1mo ago +10.0%1w ago +13.7%1d ago +9.0%
Returns since
7d -3.8%30d -0.5%90d -1.8%180d -15.0%1y -15.0%

IONS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
IONS since 2026-03-05Filed 182 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0000874015-26-000134
Common Stock
Transaction date
Mar 03, 2026
Filed Mar 05, 2026, 12:00 AM · 2d delay
Shares
48.6k sh
$6.08k per share
Estimated value
$296M
Computed from shares × price
Holdings after
165k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Holdings Increase 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, Chief Scientific Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 19, 2025.

  2. F2

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.60 to $79.60 inclusive. The reporting person undertakes to provi…

  3. F3

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.605 to $80.555 inclusive. The reporting person undertakes to pro…

  4. F4

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.61 to $81.07 inclusive. The reporting person undertakes to provi…

Original filing · 0000874015-26-000134
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

IONS